Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
LEO PHARMA A/S
A/S
Active
CVR 56759514
Industriparken 55, 2750
Ballerup
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 1962 · 64 years old
1070 employees
Overvåg
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
LEO PHARMA A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
4B
7B
11B
15B
9.6B
2021
12.9B
2022
11.5B
2023
12.5B
2024
11.5B
2025
EBITDA
DKK millions
474M
-1630M
-3733M
-5837M
-7940M
-6352M
2021
-4614M
+27%
2022
-4183M
+9%
2023
-1143M
+73%
2024
379M
+133%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
9.606.000
12.935.000
11.497.000
12.453.000
11.497.000
Staff expenses
-1.882.000
-1.751.000
-1.614.000
-0
—
EBITDA
-6.352.000
-4.614.000
-4.183.000
-1.143.000
379.000
Depreciation & amort.
-0
-0
-0
-0
—
EBIT
-6.352.000
-4.614.000
-4.183.000
-1.143.000
379.000
Net financials
1.165.000
453.000
793.000
-814.000
1.121.000
Profit before tax
5.188.000
-4.161.000
-3.390.000
-1.957.000
1.500.000
Tax
-308.000
-13.000
250.000
-181.000
-973.000
Net profit
4.880.000
-4.148.000
-3.640.000
-1.776.000
2.473.000
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
28.148.000
29.743.000
19.939.000
20.151.000
19.452.000
Equity
5.619.000
1.942.000
4.488.000
2.704.000
5.184.000
Long-term debt
9.753.000
14.428.000
10.891.000
11.219.000
8.688.000
Short-term debt
12.503.000
12.987.000
4.444.000
4.757.000
5.456.000
Total debt
22.529.000
27.801.000
15.335.000
17.447.000
14.144.000
Financial ratios
5-year trend
EBITDA-margin
3.3%
This company
15.8%
Market median
-79% vs market
2021
2025
Soliditetsgrad
26.7%
This company
38.2%
Market median
-30% vs market
2021
2025
Egenkapitalforrentning
47.7%
This company
18.4%
Market median
+159% vs market
2021
2025
Nettoresultatgrad
21.5%
This company
8.1%
Market median
+165% vs market
2021
2025
Aktivomsætning
0.59×
This company
1.12×
Market median
-47% vs market
2021
2025
Gæld/egenkapital
2.75×
This company
0.62×
Market median
-344% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on LEO PHARMA A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
